Life Sciences Virtual Event

About

Speakers

Digital Content Hub

Agenda

About

Speakers

Digital Content Hub

Agenda

JOIN NOW

VIEW SESSIONS ON DEMAND EVENT DATE: 5.21.21

Life Sciences Virtual Event

All eyes are on the life sciences sector as digital transformation and innovation booms. Biopharma and medtech companies reacted quickly during the pandemic to accelerate clinical trials and drug development focused on COVID-19 while also advancing important gene therapies and precision medicine initiatives. These companies also made strides in data management and are poised to create extreme value for healthcare over the next few years. On May 21st, life science experts will come together for a robust 90-minute program to debate the biggest issues and exciting technologies in the industry today. Join us for this unique, focused event and gain an edge on the competition.

Stay informed with our virtual learning opportunities. Check out our Webinars, Whitepapers, and our E-Newsletters today!

Stay Connected

Lynne Georgopoulos, NP & VP of Regulatory Strategy at Certara – Addressing Challenges in Pediatric Drug Development

Joshua Free, Chief Pharmacy Officer at Salem Health

Alexander Pham, Director of Pharmacy Strategy and Business Development at Boston Medical Center

Karen Ignagni, CEO of EmblemHealth

Dr. Donna Havens, Dean and Professor at the College of Nursing at Villanova University and Dr. Peter Kaufmann, Associate Dean of Research and Innovation at the College of Nursing at Villanova University

Podcasts

AGENDA

speakers

digital hub

Life Sciences Virtual Event

VIEW ON DEMAND

RSVP NOW

Add to Calendar GMail | Outlook | iCal

SPECIAL THANKS TO OUR CORPORATE SPONSORS:

WATCH NOW

Dr. Jim Woody, Chief Executive Officer, 180 Life Sciences Dr. Seth Lederman, Chief Executive Officer, Tonix Pharmaceuticals Dr. Leen Kawas, President and Chief Executive Officer, Athira Matthias Kleinz, DVM, PhD, Vice President, Translational Programs, UPMC Enterprises

How biopharma and medtech companies will create value in the next 24 months

2:25 PM CT | Panel discussion

View On Demand

Join Session Now

Discussion Topics: • How biopharma and medtech companies will create value in the next 24 months • Digital transformation in medtech and the evolution of data management • Innovations in drug pricing, manufacturing, distribution and reimbursement • Gene therapies, precision medicine and real-time data for better patient outcomes • The best bets and investments for medtech and pharma companies: Technology, corporate social responsibility and more Full agenda coming soon!

Matthias Kleinz, DVM, PhD, Vice President, Translational Programs, UPMC Enterprises

Monique Fayad, Chief Executive Officer, Trellus Health

Robert W. Fields, M,D MHA, Senior Vice President, Chief Medical Officer, Population Health, Mount Sinai Health System

Manoja Lecamwasam, PhD, System Vice President of Intellectual Property, Life Sciences and Device, Strategic Innovation, CommonSpirit

thank you to our sponsor:

Terry Myerson, Chief Executive Officer, Truveta

Erik Lium, President, Mount Sinai Innovation Partners, Executive Vice President and Chief Commercial Innovation Officer, Mount Sinai Health System

Brian Culley, Chief Executive Officer, Lineage Cell Therapeutics

Rick Anderson, President and General Manager, North America, DarioHealth

Vlado Bosanac, Chairman and Chief Executive Officer, Advanced Human Imaging (AHI)

Dr. Leen Kawas, President and Chief Executive Officer, Athira

Dr. Seth Lederman, Chief Executive Officer, Tonix Pharmaceuticals

Dr. Jim Woody, Chief Executive Officer, 180 Life Sciences

Dr. Paul Wotton, Chief Executive Officer, Obsidian Therapeutics

Digital transformation in medtech and the evolution of data management

Vlado Bosanac, Chairman and Chief Executive Officer, Advanced Human Imaging (AHI) Rick Anderson, president and general manager, North America, DarioHealth Monique Fayad, CEO, Trellus Health

1:45 PM CT | Panel discussion

View On Demand

Join Session Now

Innovations in drug pricing, manufacturing, distribution and reimbursement

Brian Culley, Chief Executive Officer, Lineage Cell Therapeutics Karen Zaderej, Chief Executive Officer, Axogen

2:25 PM CT | Panel discussion

View On Demand

Join Session Now

Executing population health at scale - what’s actually required

Bruce Darrow MD, PhD, Senior Vice President, Information Technology, Deputy Chief Information Officer, Chief Medical Information Officer, Mount Sinai Health System Robert W. Fields, MD MHA, SVP, CMO Population Health, Mount Sinai Health System Erik Lium, President of Mount Sinai Innovation Partners, EVP and Chief Commercial Innovation Officer, Mount Sinai Health System Kristin Myers, CIO and Dean of Technology, Mount Sinai Health System Tom McLain, President, RenalytixAI

1:45 Pm CT | Panel discussion

View On Demand

Join Session Now

Gene therapies, precision medicine and real-time data for better patient outcomes

Manoja Lecamwasam, PhD, System Vice President of Intellectual Property, Life Sciences and Device, Strategic Innovation, CommonSpirit Terry Myerson, Chief Executive Officer, Truveta Sara Barrington, Chief Executive Officer, VericiDx Mike Clayman, Chief Executive Officer, Flexion Therapeutics Paul Wotton, PhD, Chief Executive Officer, Obsidian Therapeutics

1:00 Pm CT | Panel discussion

View On Demand

Join Session Now

RSVP NOW

JOIN NOW

VIEW ON DEMAND

Kristin Myers, CIO and Dean of Technology, Mount Sinai Health System

Sara Barrington, Chief Executive Officer, VericiDx

Bruce Darrow MD, PhD, Senior Vice President, Information Technology, Deputy Chief Information Officer, Chief Medical Information Officer, Mount Sinai Health System; Associate Professor, Cardiology/Medicine, Mount Sinai Hospital

Ofra Weinberger, PhD, Associate Vice President for IP and Technology Transfer, Columbia University

The best bets and investments for medtech and pharma companies

Richard Brand, Chief Financial Officer, DiaCarta James McCullough, Chief Executive Officer, RenalytixAI Ofra Weinberger, PhD, Associate Vice President for IP and Technology Transfer, Columbia University

1:00 PM CT | Panel discussion

View On Demand

Join Session Now

Technology, corporate social responsibility and more

James McCullough, Chief Executive Officer, RenalytixAI

Tom McLain, President, RenalytixAI

Richard Brand, Chief Financial Officer, DiaCarta

Karen Zaderej, Chief Executive Officer, Axogen

About

Speakers

Digital Content Hub

Agenda

About

Speakers

Digital Content Hub

Agenda

JOIN NOW

VIEW ON DEMAND

RSVP NOW

Session description Attendees will learn about how virtual health can: • Expand consumer and clinician access • Improve clinical outcome • Enhance consumer experience

Bill Fera, MD, Principal, Deloitte Consulting LLP

Ken Abrams, MD, Consulting Managing Director, Deloitte Consulting, LLP

Urvi Shah, Senior Manager, Deloitte Consulting LLP

session title